[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:AZR":3,"prompts:company:0001513525":22,"buybacks:0001513525:12":49,"months:0001513525:36":83,"side:events:0001513525":86,"filings:0001513525":98},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001513525","Azora Therapeutics, Inc.","AZR","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:AZR","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":14,"has_active_program":18,"authorized_total":52,"remaining_total":60,"nearest_expiration":63,"programs":65,"recent_quarters":81,"did_asr":15,"asrs":82},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-06-30",{"value":53,"status":54,"as_of":51,"source":55},4.25,"reported",{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},"0001213900-26-090051","10-Q","2026-08-14","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1513525\u002F000121390026090051\u002F",{"value":53,"status":61,"as_of":51,"source":62},"estimated",{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},{"value":14,"status":64,"as_of":14,"source":14},"not_found",[66],{"authorized":67,"unit":69,"authorized_as_stated":70,"price_as_of":14,"date_authorized":72,"expiration_date":75,"remaining":76,"remaining_as_stated":78,"description":80},{"value":53,"status":54,"as_of":51,"source":68},{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},"usd",{"value":53,"status":54,"as_of":51,"source":71},{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},{"value":73,"status":54,"as_of":51,"source":74},"2026-08-12",{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},{"value":14,"status":64,"as_of":14,"source":14},{"value":53,"status":61,"as_of":51,"source":77},{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},{"value":53,"status":61,"as_of":51,"source":79},{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},"Purchase Agreement Amendment decreased the Minimum Issuance Price from $4.25 to $4.00",[],[],{"company":84,"data_as_of":51,"items":85},{"cik":6,"name":7,"ticker":8,"exchange":9},[],{"view":87,"sort":88,"total":89,"generated_at":90,"items":91,"next_cursor":14},"all","newest",1,"2026-11-20T10:02:28.184767Z",[92],{"id":93,"type":94,"event_date":73,"company":95,"amount_usd":53,"amount_estimated":15,"shares":14,"headline":96,"source":97},"4000a793-853d-5bb2-bddb-c331d394d7d8","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"Azora Therapeutics, Inc. authorizes $4 share repurchase program",{"accession":56,"form":57,"as_of":51,"filed_at":58,"url":59},{"company":99,"items":100,"edgar_url":106},{"cik":6,"name":7,"ticker":8,"exchange":9},[101],{"accession":56,"form":57,"filed_at":102,"period_end":51,"url":59,"used_for":103},"2026-08-14T16:07:46Z",[104,105],"programs","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001513525"]